Wageningen University, The Netherlands.
Drug Metab Dispos. 2010 Apr;38(4):617-25. doi: 10.1124/dmd.109.031047. Epub 2010 Jan 7.
Phase II metabolism by UDP-glucuronosyltransferases (UGTs) and sulfotransferases (SULTs) is the predominant metabolic pathway during the first-pass metabolism of hesperetin (4'-methoxy-3',5,7-trihydroxyflavanone). In the present study, we have determined the kinetics for glucuronidation and sulfonation of hesperetin by 12 individual UGT and 12 individual SULT enzymes as well as by human or rat small intestinal, colonic, and hepatic microsomal and cytosolic fractions. Results demonstrate that hesperetin is conjugated at positions 7 and 3' and that major enzyme-specific differences in kinetics and regioselectivity for the UGT and SULT catalyzed conjugations exist. UGT1A9, UGT1A1, UGT1A7, UGT1A8, and UGT1A3 are the major enzymes catalyzing hesperetin glucuronidation, the latter only producing 7-O-glucuronide, whereas UGT1A7 produced mainly 3'-O-glucuronide. Furthermore, UGT1A6 and UGT2B4 only produce hesperetin 7-O-glucuronide, whereas UGT1A1, UGT1A8, UGT1A9, UGT1A10, UGT2B7, and UGT2B15 conjugate both positions. SULT1A2 and SULT1A1 catalyze preferably and most efficiently the formation of hesperetin 3'-O-sulfate, and SULT1C4 catalyzes preferably and most efficiently the formation of hesperetin 7-O-sulfate. Based on expression levels SULT1A3 and SULT1B1 also will probably play a role in the sulfo-conjugation of hesperetin in vivo. The results help to explain discrepancies in metabolite patterns determined in tissues or systems with different expression of UGTs and SULTs, e.g., hepatic and intestinal fractions or Caco-2 cells. The incubations with rat and human tissue samples support an important role for intestinal cells during first-pass metabolism in the formation of hesperetin 3'-O-glucuronide and 7-O-glucuronide, which appear to be the major hesperetin metabolites found in vivo.
黄烷酮(4′-甲氧基-3′,5,7-三羟基黄酮)在首过代谢中主要通过 UDP-葡糖醛酸基转移酶(UGTs)和磺基转移酶(SULTs)进行 II 相代谢。本研究测定了 12 种 UGT 和 12 种 SULT 酶以及人或大鼠小肠、结肠和肝微粒体和胞质部分催化黄烷酮葡糖醛酸化和磺化的动力学。结果表明,黄烷酮在 7 位和 3'位发生共轭,UGT 和 SULT 催化的共轭反应在动力学和区域选择性方面存在显著的酶特异性差异。UGT1A9、UGT1A1、UGT1A7、UGT1A8 和 UGT1A3 是催化黄烷酮葡糖醛酸化的主要酶,后者仅产生 7-O-葡糖苷酸,而 UGT1A7 主要产生 3'-O-葡糖苷酸。此外,UGT1A6 和 UGT2B4 仅产生黄烷酮 7-O-葡糖苷酸,而 UGT1A1、UGT1A8、UGT1A9、UGT1A10、UGT2B7 和 UGT2B15 则共轭两个位置。SULT1A2 和 SULT1A1 优先且高效地催化黄烷酮 3'-O-硫酸盐的形成,SULT1C4 优先且高效地催化黄烷酮 7-O-硫酸盐的形成。基于表达水平,SULT1A3 和 SULT1B1 也可能在黄烷酮的磺基共轭体内发挥作用。这些结果有助于解释在 UGT 和 SULT 表达不同的组织或系统中确定的代谢物模式的差异,例如肝和肠部分或 Caco-2 细胞。用大鼠和人组织样本进行孵育支持肠道细胞在首过代谢中形成黄烷酮 3'-O-葡糖苷酸和 7-O-葡糖苷酸的重要作用,这两种物质似乎是体内发现的主要黄烷酮代谢物。